The diagnosis and medical management of advanced neuroendocrine tumors.
The DOI matches its Crossref record; 657 of the 670 references it cites were found in a registry or an index.
Abstract
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the pituitary, the parathyroids, and the (neuroendocrine) adrenal, as well as endocrine islets within glandular tissue (thyroid or pancreatic) and cells dispersed between exocrine cells, such as endocrine cells of the digestive (gastroenteropancreatic) and respiratory tracts. Conventionally, NETs may present with a wide variety of functional or nonfunctional endocrine syndromes and may be familial and have other associated tumors. Assessment of specific or general tumor markers offers high sensitivity in establishing the diagnosis and can also have prognostic significance. Imaging modalities include endoscopic ultrasonography, computed tomography and magnetic resonance imaging, and particularly, scintigraphy with somatostatin analogs and metaiodobenzylguanidine. Successful treatment of disseminated NETs requires a multimodal approach; radical tumor surgery may be curative but is rarely possible. Well-differentiated and slow-growing gastroenteropancreatic tumors should be treated with somatostatin analogs or alpha-interferon, with chemotherapy being reserved for poorly differentiated and progressive tumors. Therapy with radionuclides may be used for tumors exhibiting uptake to a diagnostic scan, either after surgery to eradicate microscopic residual disease or later if conventional treatment or biotherapy fails. Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
In the citing paper
“Although the results with a given method reflect the experience and expertise with that method at a given center, computed tomography, MRI, and transabdominal ultrasonography detect most insulinomas (71-73).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
Citations
Cites
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., GORDON, H., CARPENTER, P. C., SHENOY, B. V., & W. GO, V. L. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,114
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Moertel, C. G., Lefkopoulo, M., Lipsitz, S., Hahn, R. G., & Klaassen, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260804 · Cited by 976
Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
SERVICE, F. J., McMAHON, M. M., O'BRIEN, P. C., & BALLARD, D. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62083-7 · Cited by 883
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
Moertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O'Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
Travis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., & Koss, M. N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00003 · Cited by 807
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
LAMBERTS, S. W. J., KRENNING, E. P., & REUBI, J.-C. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-450 · Cited by 805
A Southwest Oncology Group study
Jenkins, T. R., Tangen, C. M., Macdonald, J. S., Weiss, G. R., Chapman, R. M., & Hantel, A. (1993) · Cited by 773
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Kulke, M. H., & Mayer, R. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401107 · Cited by 741
Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography
Rösch, T., Lightdale, C. J., Botet, J. F., Boyce, G. A., Sivak, M. V., Yasuda, K., Heyder, N., Palazzo, L., Dancygier, H., Schusdziarra, V., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262601 · Cited by 713
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Kebebew, E., Ituarte, P. H. G., Siperstein, A. E., Duh, Q.-Y., & Clark, O. H. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1139::aid-cncr26>3.0.co;2-z · Cited by 684
Moertel, C. G., Hanley, J. A., & Johnson, L. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032101 · Cited by 659
Rindi, G., Luinetti, O., Cornaggia, M., Capella, C., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90266-f · Cited by 644
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Benign Paragangliomas: Clinical Presentation and Treatment Outcomes in 236 Patients
Erickson, D. Z., Kudva, Y. C., Ebersold, M. J., Thompson, G. B., Grant, C. S., van Heerden, J. A., & Young, W. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5210 · Cited by 625
Hepatic neuroendocrine metastases: does intervention alter outcomes?1
Chamberlain, R. S., Canes, D., Brown, K. T., Saltz, L., Jarnagin, W., Fong, Y., & Blumgart, L. H. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00222-2 · Cited by 622
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Pacak, K., Linehan, W. M., Eisenhofer, G., Walther, M. M., & Goldstein, D. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00016 · Cited by 618
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
Pellikka, P. A., Tajik, A. J., Khandheria, B. K., Seward, J. B., Callahan, J. A., Pitot, H. C., & Kvols, L. K. (1993) · Circulation · doi:10.1161/01.cir.87.4.1188 · Cited by 614
Insulin-like growth factors and cancer
Macaulay, V. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.65 · Cited by 601
Carlomagno, F., Vitagliano, D., Guida, T., Ciardiello, F., Tortora, G., Vecchio, G., Ryan, A. J., Fontanini, G., Fusco, A., & Santoro, M. M. (2002) · PubMed · Cited by 569
Khanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., & Klausner, J. S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7 · Cited by 561
Revised classification of neuroendocrine tumours of the lung, pancreas and gut
Capella, C., Heitz, P. U., H�fler, H., Solcia, E., & Kl�ppel, G. (1995) · Virchows Archiv · doi:10.1007/bf00199342 · Cited by 553
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
Machens, A., Niccoli-Sire, P., Hoegel, J., Frank-Raue, K., van Vroonhoven, T. J., Roeher, H.-D., Wahl, R. A., Lamesch, P., Raue, F., Conte-Devolx, B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa012915 · Cited by 545
Surgery to Cure the Zollinger–Ellison Syndrome
Norton, J. A., Fraker, D. L., Alexander, H. R., Venzon, D. J., Doppman, J. L., Serrano, J., Goebel, S. U., Peghini, P. L., Roy, P. K., Gibril, F., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410902 · Cited by 504
Service, F. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321707 · Cited by 503
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
Synaptophysin: a marker protein for neuroendocrine cells and neoplasms.
Wiedenmann, B., Franke, W. W., Kuhn, C., Moll, R., & Gould, V. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3500 · Cited by 496
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
Pheochromocytoma: State-of-the-Art and Future Prospects
Bravo, E. L., & Tagle, R. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0013 · Cited by 493
Erickson, J. D., Schafer, M. K., Bonner, T. I., Eiden, L. E., & Weihe, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.5166 · Cited by 479
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
O'Connor, D. T., & Deftos, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605013141803 · Cited by 477
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
Hofland, L. J., & Lamberts, S. W. J. (2003) · Endocrine Reviews · doi:10.1210/er.2000-0001 · Cited by 474
Karnofsky memorial lecture. An odyssey in the land of small tumors.
Moertel, C. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1502 · Cited by 473
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Weber, H. C., Venzon, D. J., Lin, J.-T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., Norton, J. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90124-8 · Cited by 467
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
Neumann, H., Berger, D. P., Sigmund, G., Blum, U., Schmidt, D., Parmer, R. J., Volk, B., & Kirste, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292103 · Cited by 465
Clinical Experience Over 48 Years With Pheochromocytoma
Goldstein, R. E., O’Neill, J. A., Holcomb, G. W., Morgan, W. M., Neblett, W. W., Oates, J. A., Brown, N., Nadeau, J., Smith, B., Page, D. L., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00001 · Cited by 464
Hepatic resection for metastatic neuroendocrine carcinomas
Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J., & Kvols, L. K. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80107-x · Cited by 462
Stratakis, C. A., Carney, J. A., Lin, J. P., Papanicolaou, D. A., Karl, M., Kastner, D. L., Pras, E., & Chrousos, G. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118467 · Cited by 459
Autoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid Tumors
Rönnblom, L. E., Alm, G. V., & Öberg, K. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-178 · Cited by 455
Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
Janson, E. T., Holmberg, L., Stridsberg, M., Eriksson, B., Theodorsson, E., Wilander, E., & öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008215730767 · Cited by 455
Gibril, F., Reynolds, J. C., Doppman, J. L., Chen, C. C., Venzon, D. J., Termanini, B., Weber, H. C., Stewart, C. A., & Jensen, R. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00005 · Cited by 440
Valkema, R., de Jong, M., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Lugtenburg, P. J., de Jong, F. H., Christiansen, A., Kam, B. L. R., de Herder, W. W., et al. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc/2002.31025 · Cited by 435
Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900026 · Cited by 433
Averbuch, S. D., Steakley, C. S., Young, R. C., Gelmann, E. P., Goldstein, D. S., Stull, R., & Keiser, H. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-267 · Cited by 427
Carcinoid Tumor of the Appendix: Treatment and Prognosis
Moertel, C. G., Weiland, L. H., Nagorney, D. M., & Dockerty, M. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172704 · Cited by 427
Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography.
Legmann, P., Vignaux, O., Dousset, B., Baraza, A. J., Palazzo, L., Dumontier, I., Coste, J., Louvel, A., Roseau, G., Couturier, D., et al. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.5.9574609 · Cited by 425
Yttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Somatic mutation of the MEN1 gene in parathyroid tumours
Heppner, C., Kester, M. B., Agarwal, S. K., Debelenko, L. V., Emmert-Buck, M. R., Guru, S. C., Manickam, P., Olufemi, S.-E., Skarulis, M. C., Doppman, J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-375 · Cited by 415
Fink, G., Krelbaum, T., Yellin, A., Bendayan, D., Saute, M., Glazer, M., & Kramer, M. R. (2001) · Chest · doi:10.1378/chest.119.6.1647 · Cited by 415
Robiolio, P. A., Rigolin, V. H., Wilson, J. S., Harrison, J. K., Sanders, L. L., Bashore, T. M., & Feldman, J. M. (1995) · Circulation · doi:10.1161/01.cir.92.4.790 · Cited by 406
Anderson, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01272-7 · Cited by 399
Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
Pipeleers-Marichal, M., Somers, G., Willems, G., Foulis, A., Imrie, C., Bishop, A. E., Polak, J. M., Häcki, W. H., Stamm, B., Heitz, P. U., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003153221103 · Cited by 396
Evolving Concepts in the Pathophysiology, Diagnosis, and Treatment of Pheochromocytoma
BRAVO, E. L. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-356 · Cited by 393
Rubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Adams, S., Baum, R., Rink, T., Schumm-Dräger, P.-M., Usadel, K.-H., & Hör, G. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050197 · Cited by 387
Isolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?
Chen, H., Hardacre, J. M., Uzar, A., Cameron, J. L., & Choti, M. A. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00099-4 · Cited by 371
Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r · Cited by 363
VON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS
Walther, M. M., Herring, J., Enquist, E., Keiser, H. R., & Linehan, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68171-2 · Cited by 361
Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Erasmus, J. J., McAdams, H. P., Patz, E. F., Coleman, R. E., Ahuja, V, & Goodman, P. C. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.5.9574618 · Cited by 357
Rindi, G., Azzoni, C., Rosa, S. L., Klersy, C., Paolotti, D., Rappel, S., Stolte, M., Capella, C., Bordi, C., & Solcia, E. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70174-5 · Cited by 354
Nobels, F. R. E., Kwekkeboom, D. J., Coopmans, W., Schoenmakers, C. H. H., Lindemans, J., De Herder, W. W., Krenning, E. P., Bouillon, R., & Lamberts, S. W. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4145 · Cited by 352
Zollinger-Ellison Syndrome: Clinical Presentation in 261 Patients
Roy, P. K., Venzon, D. J., Shojamanesh, H., Abou-Saif, A., Peghini, P., Doppman, J. L., Gibril, F., & Jensen, R. T. (2000) · Medicine · doi:10.1097/00005792-200011000-00004 · Cited by 351
Pancreatic Islet Cell Carcinoma: II. Results of Therapy with Streptozotocin in 52 Patients
BRODER, L. E., & CARTER, S. K. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-79-1-108 · Cited by 349
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
de Jong, M., Valkema, R., Jamar, F., Kvols, L. K., Kwekkeboom, D. J., Breeman, W. A. P., Bakker, W. H., Smith, C., Pauwels, S., & Krenning, E. P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31027 · Cited by 346
Shapiro, B., Copp, J., Sisson, J. C., Eyre, P., Wallis, J. W., & Beierwaltes, W. H. (1985) · PubMed · Cited by 344
Yu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., & Jensen, R. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.615 · Cited by 341
Specific Endocrine Tissue Marker Defined by a Monoclonal Antibody
Lloyd, R. V., & Wilson, B. S. (1983) · Science · doi:10.1126/science.6635661 · Cited by 337
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
Peptide receptor imaging and therapy.
Kwekkeboom, D. J., Krenning, E. P., & de Jong, M. (2000) · PubMed · Cited by 330
The RET Proto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
Eng, C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351307 · Cited by 328
Chang, V. T., Hwang, S. S., Feuerman, M., & Kasimis, B. S. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1175::aid-cncr30>3.0.co;2-n · Cited by 326
The Glucagonoma Syndrome Clinical and Pathologic Features in 21 Patients
Wermers, R. A., Fatourechi, V., Wynne, A. G., Kvols, L. K., & Lloyd, R. V. (1996) · Medicine · doi:10.1097/00005792-199603000-00002 · Cited by 322
Neuroendocrine Carcinomas (Carcinoid Tumor) of the Thymus
Moran, C. A., & Suster, S. (2000) · American Journal of Clinical Pathology · doi:10.1309/3pdn-pmt5-eqtm-h0cd · Cited by 318
Caplin, M. E., Buscombe, J. R., Hilson, A. J., Jones, A. L., Watkinson, A. F., & Burroughs, A. K. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02286-7 · Cited by 309
Effect of Surgery on the Outcome of Midgut Carcinoid Disease with Lymph Node and Liver Metastases
Hellman, P., Lundström, T., Öhrvall, U., Eriksson, B., Skogseid, B., Öberg, K., Tiensuu Janson, E., & Åkerström, G. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6630-z · Cited by 300
Tumor Markers in Neuroendocrine Tumors
Eriksson, B., Öberg, K., & Stridsberg, M. (2000) · Digestion · doi:10.1159/000051853 · Cited by 299
Factors Associated with Progression of Carcinoid Heart Disease
Møller, J. E., Connolly, H. M., Rubin, J., Seward, J. B., Modesto, K., & Pellikka, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021451 · Cited by 298
Di Bartolomeo, M., Bajetta, E., Buzzoni, R., Mariani, L., Carnaghi, C., Somma, L., Zilembo, N., Di Leo, A., & ITMO Association (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<402::aid-cncr25>3.0.co;2-4 · Cited by 296
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang, Z., Vortmeyer, A. O., Pack, S., Huang, S., Pham, T. A., Wang, C., Park, W. S., Agarwal, S. K., Debelenko, L., Kester, M. B., et al. (1997) · PubMed · Cited by 294
The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas
Moertel, C. G., Johnson, C. M., McKusick, M. A., Martin, J. K., Nagorney, D. M., Kvols, L. K., Rubin, J., & Kunselman, S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00008 · Cited by 292
Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium
Doppman, J. L., Chang, R., Fraker, D. L., Norton, J. A., Alexander, H. R., Miller, D. L., Collier, E., Skarulis, M. C., & Gorden, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00004 · Cited by 286
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies
Anthony, L. B., Woltering, E. A., Espenan, G. D., Cronin, M. D., Maloney, T. J., & McCarthy, K. E. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31769 · Cited by 279
Expression of vascular endothelial growth factor in digestive neuroendocrine tumours
Terris, Scoazec, Rubbia, Bregeaud, Pepper, Ruszniewski, Belghiti, FLÉjou, & Degott (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00321.x · Cited by 279
Loh, K.-C., Fitzgerald, P. A., Matthay, K. K., Yeo, P. P. B., & Price, D. C. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03348026 · Cited by 278
Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel, C. G., & Hanley, J. A. (1979) · PubMed · Cited by 277
Islet Cell Tumor of the Pancreas: Biphasic CT versus MR Imaging in Tumor Detection
Ichikawa, T., Peterson, M. S., Federle, M. P., Baron, R. L., Haradome, H., Kawamori, Y., Nawano, S., & Araki, T. (2000) · Radiology · doi:10.1148/radiology.216.1.r00jl26163 · Cited by 275
Kaltsas, G. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.895 · Cited by 275
Self-citationCohen, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.919 · Cited by 274
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Anderson, C. J., Dehdashti, F., Cutler, P. D., Schwarz, S. W., Laforest, R. A., Bass, L. A., Lewis, J. S., & Mccarthy, D. W. (2001) · PubMed · Cited by 273
Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
Schally, A., & Nagy, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410001 · Cited by 271
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
Engstrom, P. F., Lavin, P. T., Moertel, C. G., Folsch, E., & Douglass, H. O. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.11.1255 · Cited by 270
Psychiatric morbidity in terminally III cancer patients: A prospective study
Minagawa, H., Uchitomi, Y., Yamawaki, S., & Ishitani, K. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960901)78:5<1131::aid-cncr26>3.0.co;2-2 · Cited by 268
Khan, M. A., Herzog, C. A., St. Peter, J. V., Hartley, G. G., Madlon-Kay, R., Dick, C. D., Asinger, R. W., & Vessey, J. T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391101 · Cited by 265
A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve Regurgitation
Jick, H., Vasilakis, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., & Derby, L. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391102 · Cited by 263
Treatment with cisplatin and etoposide in patients with neuroendocrine tumors
Fj�llskog, M.-L. H., Granberg, D. P. K., Welin, S. L. V., Eriksson, C., �berg, K. E., Janson, E. T., & Eriksson, B. K. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1101::aid-cncr1426>3.0.co;2-v · Cited by 262
Andrews, J. C., Walker, S., Ackermann, R. J., Cotton, L., Ensminger, W. D., & Shapiro, B. (1994) · PubMed · Cited by 261
Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases
Siperstein, A. E., Rogers, S. J., Hansen, P. D., & Gitomirsky, A. (1997) · Surgery · doi:10.1016/s0039-6060(97)90221-x · Cited by 260
Epidemiology and survival in patients with carcinoid disease in the Netherlands
Quaedvlieg, P. F. H. J., Visser, O., Lamers, C. B. H. W., Janssen-Heijen, M. L. G., & Taal, B. G. (2001) · Annals of Oncology · doi:10.1023/a:1012272314550 · Cited by 260
Saltz, L., Trochanowski, B., Buckley, M., Heffernan, B., Niedzwiecki, D., Tao, Y., & Kelsen, D. (1993) · Cancer · doi:10.1002/1097-0142(19930701)72:1<244::aid-cncr2820720143>3.0.co;2-q · Cited by 260
The Laboratory Diagnosis of Adrenal Pheochromocytoma: The Mayo Clinic Experience
Kudva, Y. C., Sawka, A. M., & Young, W. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030720 · Cited by 259
Morphologic studies of the liver cell dysplasia
Watanabe, S., Okita, K., Harada, T., Kodama, T., Numa, Y., Takemoto, T., & Takahashi, T. (1983) · Cancer · doi:10.1002/1097-0142(19830615)51:12<2206::aid-cncr2820511209>3.0.co;2-b · Cited by 258
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung
Debelenko, L. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2285 · Cited by 257
Virgolini, I., Raderer, M., Kurtaran, A., Angelberger, P., Banyai, S., Yang, Q., Li, S., Banyai, M., Pidlich, J., Niederle, B., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410273311703 · Cited by 257
Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
Hirshberg, B., Livi, A., Bartlett, D. L., Libutti, S. K., Alexander, H. R., Doppman, J. L., Skarulis, M. C., & Gorden, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6807 · Cited by 256
Thoeni, R. F., Mueller-Lisse, U. G., Chan, R., Do, N. K., & Shyn, P. B. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe32483 · Cited by 256
Aggressive surgery for metastatic liver neuroendocrine tumors
Norton, J. A., Warren, R. S., Kelly, M. G., Zuraek, M. B., & Jensen, R. T. (2003) · Surgery · doi:10.1016/j.surg.2003.07.025 · Cited by 255
The gut as the largest endocrine organ in the body
Ahlman, H., & Nilsson, O. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s63 · Cited by 254
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members
Watson, P., Lin, K. M., Rodriguez-Bigas, M. A., Smyrk, T., Lemon, S., Shashidharan, M., Franklin, B., Karr, B., Thorson, A., & Lynch, H. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980715)83:2<259::aid-cncr9>3.0.co;2-l · Cited by 253
[123I]Metaiodobenzylguanidine and[111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1
van der Harst, E., de Herder, W. W., Bruining, H. A., Bonjer, H. J., de Krijger, R. R., Lamberts, S. W. J., van de Meiracker, A. H., Boomsma, F., Stijnen, T., Krenning, E. P., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7238 · Cited by 253
Kwekkeboom, D. J., & Krenning, E. P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31022 · Cited by 252
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
Baudin, E., Gigliotti, A., Ducreux, M., Ropers, J., Comoy, E., Sabourin, J., Bidart, J., Cailleux, A., Bonacci, R., Ruffié, P., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.635 · Cited by 250
Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Moertel, C. G. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.11.727 · Cited by 245
BURKE, A. P., Thomas, R. M., Elsayed, A. M., et al. (1997) · PubMed · Cited by 244
111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial
Virgolini, I., Britton, K., Buscombe, J., Moncayo, R., Paganelli, G., & Riva, P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31565 · Cited by 243
Lebtahi, R., Cadiot, G., Sarda‐Mantel, L., Daou, D., Faraggi, M., Petegnief, Y., Mignon, M., & Guludec, D. L. (1997) · PubMed · Cited by 240
Prospective Study of Thymic Carcinoids in Patients with Multiple Endocrine Neoplasia Type 1
Gibril, F., Chen, Y.-J., Schrump, D. S., Vortmeyer, A., Zhuang, Z., Lubensky, I. A., Reynolds, J. C., Louie, A., Entsuah, L. K., Huang, K., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021314 · Cited by 240
CARCINOID TUMOURS: Frequency in a Defined Population During a 12‐Year‐Period
Berge, T., & Linell, F. (1976) · Acta Pathologica Microbiologica Scandinavica Section A Pathology · doi:10.1111/j.1699-0463.1976.tb00122.x · Cited by 238
Distribution of somatostatin receptors in normal and tumor tissue
Reubi, J. C., Kvols, L., Krenning, E., & Lamberts, S. W. J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90217-z · Cited by 234
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
Krenning, E. P., de Jong, M., Kooij, P. P. M., Breeman, W. A. P., Bakker, W. H., de Herder, W. W., van Eijck, C. H. J., Kwekkeboom, D. J., Jamar, F., Pauwels, S., et al. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s23 · Cited by 234
Zollinger–Ellison Syndrome: Current Concepts in Diagnosis and Management
Wolfe, M. M., & Jensen, R. T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711053171907 · Cited by 233
Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*
SKOGSEID, B., ERIKSSON, B., LUNDQVIST, G., LÖRELIUS, L.-E., RASTAD, J., WIDE, L., ÅKERSTRÖM, G., & ÖBERG, K. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-281 · Cited by 232
Breeman, W. A., de Jong, M., Kwekkeboom, D. J., Valkema, R., Bakker, W. H., Kooij, P. P., Visser, T. J., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100502 · Cited by 226
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
Aparicio, T., Ducreux, M., Baudin, E., Sabourin, J.-C., De Baere, T., Mitry, E., Schlumberger, M., & Rougier, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00073-9 · Cited by 226
Wymenga, A. N. M., Eriksson, B., Salmela, P. I., Jacobsen, M. B., Van Cutsem, E. J. D. G., Fiasse, R. H., Välimäki, M. J., Renstrup, J., de Vries, E. G. E., & Öberg, K. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1111 · Cited by 226
Zimmer, T., Stölzel, U., Bäder, M., Koppenhagen, K., Hamm, B., Buhr, H., Riecken, E. O., & Wiedenmann, B. (1996) · Gut · doi:10.1136/gut.39.4.562 · Cited by 223
PGP 9.5, a new marker for human neuroendocrine tumours
RODE, J., DHILLON, A. P., DORAN, J. F., JACKSON, P., & THOMPSON, R. J. (1985) · Histopathology · doi:10.1111/j.1365-2559.1985.tb02431.x · Cited by 221
A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?
Modlin, I. M., Lye, K. D., & Kidd, M. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04027.x · Cited by 217
de Jong, M., Bakker, W. H., Krenning, E. P., Breeman, W. A. P., van der Pluijm, M. E., Bernard, B. F., Visser, T. J., Jermann, E., Béhé, M., Powell, P., et al. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00881807 · Cited by 215
The Glucagonoma Syndrome: A Review of its Features and Discussion of New Perspectives
Chastain, M. A. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200105000-00003 · Cited by 213
Bronchial carcinoid tumors: A retrospective analysis of 126 patients
Harpole, D. H., Feldman, J. M., Buchanan, S., Young, W. G., & Wolfe, W. G. (1992) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(92)91139-z · Cited by 212
Carcinoids of the jejunum and ileum: An immunohistochemical and clinicopathologic study of 167 cases
Burke, A. P., Thomas, R. M., Elsayed, A. M., & Sobin, L. H. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970315)79:6<1086::aid-cncr5>3.0.co;2-e · Cited by 212
Dottorini, M. E., Assi, A., Sironi, M., Sangalli, G., Spreafico, G., & Colombo, L. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8<1556::aid-cncr20>3.0.co;2-y · Cited by 211
Termanini, B., Gibril, F., Reynolds, J., Doppman, J., Chen, C., Stewart, C., Sutliff, V., & Jensen, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024287 · Cited by 206
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Mäcke, H. R., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100490 · Cited by 206
Ruszniewski, P., Ducreux, M., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., Raymond, J. M., Dupas, J. L., Gouerou, H., Jian, R., et al. (1996) · Gut · doi:10.1136/gut.39.2.279 · Cited by 206
Carcinoid tumors of the stomach
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Surgical Oncology · doi:10.1016/s0960-7404(03)00034-3 · Cited by 205
Neuroglycopenic and other symptoms in patients with insulinomas
Dizon, A. M., Kowalyk, S., & Hoogwerf, B. J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00021-2 · Cited by 205
Janson, E. T., & Öberg, K. (1993) · Acta Oncologica · doi:10.3109/02841869309083916 · Cited by 204
A comparison between three commercial kits for chromogranin A measurements
Stridsberg, M., Eriksson, B., Oberg, K., & Janson, E. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770337 · Cited by 202
The Glucagonoma Syndrome: Clinical Features, Diagnosis, and Treatment
STACPOOLE, P. W. (1981) · Endocrine Reviews · doi:10.1210/edrv-2-3-347 · Cited by 201
Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.
Reubi, J. C. (1995) · PubMed · Cited by 198
Update in Pulmonary Carcinoid Tumors: A Review Article
Hage, R., de la Rivière, A. B., Seldenrijk, C. A., & van den Bosch, J. M. M. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.09.019 · Cited by 197
Service, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
Ducreux, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02003-7 · Cited by 196
Routine Measurement of Plasma Calcitonin in Nodular Thyroid Diseases
Vierhapper, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.5.1589 · Cited by 192
SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours
Krausz, Y., Keidar, Z., Kogan, I., Even‐Sapir, E., Bar‐Shalom, R., Engel, A., Rubinstein, R., Sachs, J., Bocher, M., Agranovicz, S., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01885.x · Cited by 192
Frank, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00146-x · Cited by 191
Carcinoids of the rectum: An evaluation of 1271 reported cases
Soga, J. (1997) · Surgery Today · doi:10.1007/bf02385898 · Cited by 190
Eriksson, B., Renstrup, J., Imam, H., & Öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008205415035 · Cited by 190
Carcinoid Tumors of the Appendix
Roggo, A., Wood, W. C., & Ottinger, L. W. (1993) · Annals of Surgery · doi:10.1097/00000658-199304000-00010 · Cited by 189
Carcinoids associated with multiple endocrine neoplasia syndromes
Duh, Q.-Y., Hybarger, C. P., Geist, R., Gamsu, G., Goodman, P. C., Gooding, G. A. W., & Clark, O. H. (1987) · The American Journal of Surgery · doi:10.1016/0002-9610(87)90305-9 · Cited by 189
Secretin injection test in the diagnosis of gastrinoma
McGuigan, J. E., & Wolfe, M. M. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90933-6 · Cited by 189
Seki, T., Wakabayashi, M., Nakagawa, T., Imamura, M., Tamai, T., Nishimura, A., Yamashiki, N., Okamura, A., & Inoue, K. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990415)85:8<1694::aid-cncr8>3.0.co;2-3 · Cited by 188
Interferon in the Management of Neuroendocrine GEP-Tumors
Öberg, K. (2000) · Digestion · doi:10.1159/000051862 · Cited by 187
Secretin and Calcium Provocative Tests in the Zollinger-Ellison Syndrome: A Prospective Study
Frucht, H., Howard, J. M., Slaff, J. I., Wank, S. A., McCarthy, D. M., Maton, P. N., Vinayek, R., Gardner, J. D., & Jensen, R. T. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-9-713 · Cited by 184
Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours
Hoefnagel, C. A. (1994) · European Journal of Nuclear Medicine · doi:10.1007/bf00173045 · Cited by 184
Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors
Feldman, J. M., & O'dorisio, T. M. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90583-8 · Cited by 184
Alexander, H. R., Fraker, D. L., Norton, J. A., Bartlett, D. L., Tio, L., Benjamin, S. B., Doppman, J. L., Goebel, S. U., Serrano, J., Gibril, F., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199808000-00013 · Cited by 180
Primary Ovarian Carcinoid Tumors
Davis, K. P., Hartmann, L. K., Keeney, G. L., & Shapiro, H. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0136 · Cited by 180
P-glycoprotein and resistance to anticancer drugs
Ling, V. (1992) · Cancer · doi:10.1002/1097-0142(19920515)69:10<2603::aid-cncr2820691034>3.0.co;2-e · Cited by 180
Adenoma versus Carcinoid Tumor of the Middle Ear: a Study of 48 Cases and Review of the Literature
Torske, K. R., & Thompson, L. D. R. (2002) · Modern Pathology · doi:10.1038/modpathol.3880561 · Cited by 179
The pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse, E., Breittmayer, F., Roche, A., De Baere, T., Indushekar, S., Ducreux, M., Lasser, P., Elias, D., & Rougier, P. (1993) · Radiology · doi:10.1148/radiology.189.2.7692465 · Cited by 172
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.
Gb, T., van Heerden, J. A., Jk, M., Schutt, A. J., Dm, I., & Carney, J. A. (1985) · PubMed · Cited by 171
Iacangelo, A. L., & Eiden, L. E. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00069-n · Cited by 169
Chiti, A., Fanti, S., Savelli, G., Romeo, A., Bellanova, B., Rodari, M., van Graafeiland, B. J., Monetti, N., & Bombardieri, E. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050314 · Cited by 168
Rigel, D. S., Rivers, J. K., Kopf, A. W., Friedman, R. J., Vinokur, A. F., Heilman, E. R., & Levenstein, M. (1989) · Cancer · doi:10.1002/1097-0142(19890115)63:2<386::aid-cncr2820630231>3.0.co;2-6 · Cited by 168
Cushing's Syndrome in Patients with the Zollinger–Ellison Syndrome
Maton, P. N., Gardner, J. D., & Jensen, R. T. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607033150101 · Cited by 168
Eriksson, B., Skogseid, B., Lundqvist, G., Wide, L., Wilander, E., & Öberg, K. (1990) · Cancer · doi:10.1002/1097-0142(19900501)65:9<1883::aid-cncr2820650902>3.0.co;2-3 · Cited by 168
Hepatic Arterial Chemoembolization for Metastatic Neuroendocrine Tumors
Clouse, M. E., Perry, L., Stuart, K., & Stokes, K. R. (1994) · Digestion · doi:10.1159/000201208 · Cited by 167
Mukherjee, J. J., Kaltsas, G. A., Islam, N., Plowman, P. N., Foley, R., Hikmat, J., Britton, K. E., Jenkins, P. J., Chew, S. L., Monson, J. P., et al. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01309.x · Cited by 167
Self-citationEriksson, B. K., Skogseid, B. M., Lundqvist, G., Wide, L., Wilander, E., & Öberg, K. (1990) · Cancer · doi:10.1002/1097-0142(19900501)65:9<2014::aid-cncr2820650922>3.0.co;2-s · Cited by 167
Carcinoid tumors of the lung: Do atypical features require aggressive management?
Marty-Ané, C.-H., Costes, V., Pujol, J.-L., Alauzen, M., Baldet, P., & Mary, H. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)00630-p · Cited by 167
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours
Öberg, K. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s111 · Cited by 167
(GETC), A. T. G. D. D. T. A. C., Schlumberger, M., Abdelmoumene, N., Delisle, M., & Couette, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.73 · Cited by 167
Koura, A. N., Giacco, G. G., Curley, S. A., Skibber, J. M., Feig, B. W., & Ellis, L. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7<1294::aid-cncr4>3.0.co;2-h · Cited by 167
GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy
Cantuaria, G., Fagotti, A., Ferrandina, G., Magalhaes, A., Nadji, M., Angioli, R., Penalver, M., Mancuso, S., & Scambia, G. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1144::aid-cncr1432>3.0.co;2-t · Cited by 166
Treatment of Type II Gastric Carcinoid Tumors with Somatostatin Analogues
Tomassetti, P., Migliori, M., Caletti, G. C., Fusaroli, P., Corinaldesi, R., & Gullo, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430805 · Cited by 166
Bordi, C., Yu, J.-Y., Baggi, M. T., Davoli, C., Pilato, F. P., Baruzzi, G., Gardini, G., Zamboni, G., Franzin, G., Papotti, M., et al. (1991) · Cancer · doi:10.1002/1097-0142(19910201)67:3<663::aid-cncr2820670323>3.0.co;2-l · Cited by 165
Approaches to the diagnosis of gut neuroendocrine tumors: The last word (today)
Modlin, I., & Tang, L. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024313 · Cited by 165
Moertel, C. G., Rubin, J., & Kvols, L. K. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.865 · Cited by 165
5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors
Bajetta, E., Rimassa, L., Carnaghi, C., Seregni, E., Ferrari, L., Bartolomeo, M. D., Regalia, E., Cassata, A., Procopio, G., & Mariani, L. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980715)83:2<372::aid-cncr23>3.0.co;2-p · Cited by 165
Service, F. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1582 · Cited by 163
Weckbecker, G., Briner, U., Lewis, I., & Bruns, C. (2002) · Endocrinology · doi:10.1210/en.2002-220219 · Cited by 163
Research works printed but not linked: 3
- Krenning, 1994, Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide., Semin Oncol, 21, 6
- Janson, 2000, Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors., J Nucl Med, 41, 1514
- Bartsch, 1990, Treatment of metastatic carcinoid tumors by recombinant human interferon-α. Results from a phase II study., J Cancer Res Clin Oncol, 116, 305
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationClinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citation
Metadata
- Authors
- Kaltsas, G. A., Besser, G. M., & Grossman, A. B.
- Affiliations
- St Bartholomew's Hospital (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 25
- Issue
- 3
- Pages
- 458-511
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2031301095
- Semantic Scholar
- b09a37699a89446c4662f1bc87eb975bf31118b7
- Cited by
- 674
- References
- 670
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 17 · 2023: 26 · 2022: 17 · 2021: 23 · 2020: 23 · 2019: 24 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 46 · 2014: 30 · 2013: 37 · 2012: 49
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- neuroendocrine tumors, diagnosis, tumor markers, endocrine syndromes, somatostatin analogues, MIBG scintigraphy, endoscopic ultrasound, interferon-alpha, chemotherapy, radionuclide therapy, multimodal therapy, quality of life
- MeSH terms
- Adrenal Gland Neoplasms, Animals, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, Humans, Pancreatic Neoplasms, Parathyroid Neoplasms, Pituitary Neoplasms, Prognosis, Quality of Life, Sensitivity and Specificity, Somatostatin, Thyroid Neoplasms, Tomography, X-Ray Computed, Biomarkers, Tumor, Interferon-alpha, Carcinoma, Neuroendocrine, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.